細胞番号 : 細胞名
RCB1641 : EL4
update : 2024/09/18
|
| 細胞特性(Comment:英) | 9,10-dimethyl-1,2benzanthracene induced lymphoma. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85023105 prior to order. |
| 細胞特性(日) | C57BL/6Nマウスに9,10-dimethyl-1,2-benzanthraceneを投与して誘導したリンパ腫。ECACC由来株。使用条件等がECACCによって随時変更となる可能性があります。ご購入前に、ECACC 85023105 を必ずご参照ください。 |
| 細胞特性(寄託者記述:英) | |
| 細胞特性(寄託者記述:日) | |
| 使用条件(英) | 1) There is no restriction regarding use for basic researches. However, since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECA85023105 prior to order. 2) In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| 使用条件(日) | 1) 基礎的研究につきましては、使用制限はありません。しかし、使用条件等がECACCによって随時変更となる可能性があるので、購入前に、ECA85023105 を必ず参照すること。2) 商業利用や特許取得を目的とする場合は、事前に必ず理研細胞バンクに連絡をすること。 |
| 備考(英) | |
| 備考(日) | |
| 提供申込書類(英) |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
| 提供申込書類(日) |
依頼書C-0001.pdf
同意書(非営利学術目的)C-0003.pdf
同意書(営利目的)C-0003p.pdf
|
|
提供同意書は、使用機関の種類や目的に応じて、非営利学術目的 (C-XXXX) と営利目的 (C-XXXXp) の2種類があります。該当する提供同意書をご使用ください（詳細）。特許等の取得及び商業利用等は事前に必ず cellbank.brc@riken.jp までご連絡ください。
|
| 提供手数料 |
手数料とお支払いについてはこちらをご覧ください。 |
|
細胞基本情報
|
|
寄託者 |
ECACC
|
| 寄託日 |
2000
|
| 動物種 |
_mouse
< Mammals
|
| 採取組織 |
ascites
|
| 病名 |
ascites lymphoma lymphoblast
|
| 転移 |
Yes
|
| 細胞分類 |
cancer
|
| 入手歴 |
overseas, ECACC -> RIKEN Cell Bank
|
|
細胞寿命 |
infinite
|
| 細胞形態 |
lymphoblast-like
|
| Cellosaurus(Expasy) |
CVCL_0255
|
|
細胞培養・検査情報
| |
寄託時情報 |
ロット情報 |
| 培地・試薬情報 |
培地・試薬一覧はこちらをご覧ください。 |
|
培養形態 |
|
Suspension cells
|
| 培養方法 |
|
General Guidelines for Culturing Suspension Cells, 浮遊細胞の培養に関する一般的な注意(Japanese)
|
| 培地 |
|
DMEM (low glucose) + 10% FBS
|
| 抗生物質 |
|
Free
|
|
継代方法 |
|
pipetting
|
|
継代密度 |
|
1 : 10 split
|
| 継代・培地交換頻度 |
|
Subculture : 2 times/week
|
| 培養最適温度 |
|
37
℃
|
| 二酸化炭素濃度 |
|
5
%
|
| 凍結培地 |
|
Medium + 10% DMSO
|
| 凍結方法 |
|
Slow freezing
|
| マイコプラズマ/アコレプラズマ |
|
(-)
|
| マウス系統検査 |
|
OK
|
| アイソザイム検査 |
|
LD, NP, PepB
|
| 画像情報 |
寄託時情報 | ロット情報 |
|
|
|
| 文献情報 |
Reference(英) |
7件
|
| Reference(日) |
0件
|
| 利用者成果(英) |
13件
|
| 利用者成果(日) |
0件
|
| Reference(英) |
|
922
Almeida JL, Dakic A, Kindig K, Kone M, Letham DLD, Langdon S, Peat R, Holding-Pillai J, Hall EM, Ladd M, Shaffer MD, Berg H, Li J, Wigger G, Lund S, Steffen CR, Fransway BB, Geraghty B, Natoli M, Bauer B, Gollin SM, Lewis DW, Reid Y.
Interlaboratory study to validate a STR profiling method for intraspecies identification of mouse cell lines
PLoS One
2019
14(6):e0218412
PubMed ID: 31220119
DOI: 10.1371/journal.pone.0218412
|
|
716
Ralph P, Nakoinz I
Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.
J Immunol
1977
119:950-54
PubMed ID: 894031
|
|
1141
Ralph P, Moore, M A, Nilsson K
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.
J Exp Med
1976
143:1528-33
PubMed ID: 1083890
DOI: 10.1084/jem.143.6.1528
|
|
2468
Herberman RB
Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
J Natl Cancer Inst
1972
48:265-71
PubMed ID: 4119883
|
|
2471
Shevach, E M, Stobo, J D, Green I
Immunoglobulin and theta-bearing murine leukemias and lymphomas.
J Immunol
1972
108:1146-51
PubMed ID: 4112916
|
|
2470
Old, L J, Boyse, E A, Stockert E
The G (Gross) leukemia antigen.
Cancer Res
1965
25:813-9
PubMed ID: 4284252
|
|
2469
Studies in antibody response of mice to tumour inoculation.
Br J Cancer
1950
4:372
PubMed ID: 14801344
DOI: 10.1038/bjc.1950.36
|
| 利用者成果(英) |
|
21764
Kazaoka A, Fujimori S, Yamada Y, Shirayanagi T, Gao Y, Kuwahara S, Sakamoto N, Susukida T, Aoki S, Ito K.
HLA-B*57:01-dependent intracellular stress in keratinocytes triggers dermal hypersensitivity reactions to abacavir.
PNAS Nexus
2024
3(4):pgae140
PubMed ID: 38628599
DOI: 10.1093/pnasnexus/pgae140
|
|
18101
Sugimoto C, Murakami Y, Ishii E, Fujita H, Wakao H.
Reprogramming and redifferentiation of mucosal-associated invariant T cells reveal tumor inhibitory activity
Elife
2022
11:e70848
PubMed ID: 35379387
DOI: 10.7554/eLife.70848
|
|
16857
Naruse C, Sugihara K, Miyazaki T, Pan X, Sugiyama F, Asano M.
A degron system targeting endogenous PD-1 inhibits the growth of tumor cells in mice
NAR Cancer
2022
4(2):zcac019
PubMed ID: 35734392
DOI: 10.1093/narcan/zcac019
|
|
19499
Nguyen TD, Miyatake Y, Yoshida T, Kawahara H, Hanayama R.
Tumor-secreted proliferin-1 regulates adipogenesis and lipolysis in cachexia
Int J Cancer
2021
148(8):1982-1992
PubMed ID: 33252827
DOI: 10.1002/ijc.33418
|
|
20272
Ma Y, Yoshida T, Matoba K, Kida K, Shintani R, Piao Y, Jin J, Nishino T, Hanayama R.
Identification of small compounds regulating the secretion of extracellular vesicles via a TIM4-affinity ELISA.
Sci Rep
2021
11(1):13471
PubMed ID: 34188113
DOI: 10.1038/s41598-021-92860-2
|
|
4184
Kimura Y, Negishi H, Matsuda A, Endo N, Hangai S, Inoue A, Nishio J, Taniguchi T, Yanai H.
Novel chemical compound SINCRO with dual function in STING-type I interferon and tumor cell death pathways.
Cancer Sci.
2018
PubMed ID: 29981256
DOI: 10.1111/cas.13726
|
|
14623
De Silva NH, Akazawa T, Wijewardana V, Inoue N, Oyamada M, Ohta A, Tachibana Y, Wijesekera DPH, Kuwamura M, Nishizawa Y, Itoh K, Izawa T, Hatoya S, Hasegawa T, Yamate J, Inaba T, Sugiura K.
Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligand
PLoS One
2017
12(11):e0188738
PubMed ID: 29190690
DOI: 10.1371/journal.pone.0188738
|
|
14127
Kanda M, Yamanaka H, Kojo S, Usui Y, Honda H, Sotomaru Y, Harada M, Taniguchi M, Suzuki N, Atsumi T, Wada H, Baghdadi M, Seino K.
Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells
Proc Natl Acad Sci U S A
2016
113(24):E3394-402
PubMed ID: 27226296
DOI: 10.1073/pnas.1604178113
|
|
18259
Acharya B, Terao S, Suzuki T, Naoe M, Hamada K, Mizuguchi H, Gotoh A.
Improving gene transfer in human renal carcinoma cells: Utilization of adenovirus vectors containing chimeric type 5 and type 35 fiber proteins
Exp Ther Med
2010
1(3):537-540
PubMed ID: 22993573
DOI: 10.3892/etm_00000085
|
|
19532
Kato K, Habu Y, Takaku H.
Non-sequence specific RNA inhibition of HIV-1 replication
Nucleic Acids Symp Ser (Oxf)
2007
(51):411-2
PubMed ID: 18029761
DOI: 10.1093/nass/nrm206
|
|
6489
Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A.
TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Arthritis Res Ther
2006
8(5):R146
PubMed ID: 16945157
DOI: 10.1186/ar2038
|
|
6976
Nagai N, Anzawa T, Satoh Y, Suzuki T, Tajima K, Munekata M.
Activities of MC3T3-E1 cells cultured on gamma-irradiated salmon atelocollagen scaffold.
J Biosci Bioeng
2006
101(6):511-4
PubMed ID: 16935254
DOI: 10.1263/jbb.101.511
|
|
1264
Sakurai T, Wakimoto N, Yamada M, Shimamura S, Motoyoshi K.
Effect of macrophage colony-stimulating factor on mouse NK 1.1+ cell activity in vivo
Int J Immunopharmacol
1998
20(8):401-13
PubMed ID: 9778101
DOI: 10.1016/s0192-0561(98)00040-x
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
